Järfälla, Sweden

Liselott Öhberg

This inventor holds 2 USPTO granted patents. Top assignees: Acturum Real Estate Ab, Arcturum Real Estate Ab. Active years: 2018-2019.


% Patents Active = 50.0

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2018-2019

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Liselott Öhberg: Innovator in Pharmaceutical Chemistry

Introduction

Liselott Öhberg is a prominent inventor based in Järfälla, Sweden. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for medical applications. With a total of 2 patents, her work focuses on addressing critical health issues such as pain, inflammation, and cancer.

Latest Patents

Öhberg's latest patents include bis(sulfonamide) derivatives and their use as mPGES inhibitors. These inventions relate to bis(sulfonamide) compounds and their pharmaceutically acceptable salts. The pharmaceutical compositions derived from these compounds are designed to serve as medicaments for the treatment and prevention of diseases where modulation of microsomal prostaglandin E synthase-1 activity is beneficial.

Career Highlights

Throughout her career, Liselott Öhberg has worked with notable companies such as Arcturum Real Estate AB and Acturum Real Estate AB. Her expertise in pharmaceutical chemistry has allowed her to develop innovative solutions that have the potential to improve patient outcomes.

Collaborations

Öhberg has collaborated with esteemed colleagues, including Peter Söderman and Mats A Svensson. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Liselott Öhberg is a trailblazer in the field of pharmaceutical chemistry, with a focus on developing innovative treatments for various health conditions. Her contributions through her patents and collaborations highlight her commitment to improving healthcare solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…